| |
 |
|
Class Information
Number: 514/54
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > Polysaccharide
Description: Subject matter wherein the organic active ingredient contains more than two saccharide radicals directly or indirectly bonded together.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6030958 |
Water insoluble derivatives of hyaluronic acid |
Feb. 29, 2000 |
| 6027715 |
Composition and means for treating dry mouth |
Feb. 22, 2000 |
| 6027733 |
Method for generating saccharide fragments |
Feb. 22, 2000 |
| 6027741 |
Sulfated hyaluronic acid and esters thereof |
Feb. 22, 2000 |
| 6028060 |
Treatment of chronic inflammatory diseases with CM101/GBS toxin |
Feb. 22, 2000 |
| 6028061 |
Angiogenesis inhibitors and use thereof |
Feb. 22, 2000 |
| 6024939 |
Contrast media for ultrasonic imaging |
Feb. 15, 2000 |
| 6024954 |
Compositions and methods for disinfecting contact lenses and preserving contact lens care products |
Feb. 15, 2000 |
| 6024959 |
Pharmaceutical composition containing pectin and a phospholipid used as an antidiarrheal and antiulcer agent |
Feb. 15, 2000 |
| 6025311 |
Fluid suspension of polysaccharides for personal care and household applications |
Feb. 15, 2000 |
| 6022728 |
Method for producing a bacterial vaccine and novel vaccines produced thereby |
Feb. 8, 2000 |
| 6022865 |
Stable aqueous solution having high concentrations of calcium and phosphate ions and solid complex |
Feb. 8, 2000 |
| 6022866 |
Use of hyaluronic acid and forms to prevent arterial restenosis |
Feb. 8, 2000 |
| 6020324 |
Glucan dietary additives |
Feb. 1, 2000 |
| 6020325 |
Method for inhibiting replication of HIV |
Feb. 1, 2000 |
| 6020326 |
Method for inhibition of bone growth by anionic polymers |
Feb. 1, 2000 |
| 6019958 |
Technetium-99m labeled peptides for imaging inflammation |
Feb. 1, 2000 |
| 6017899 |
Non-reducing saccharide-forming enzyme, its preparation and uses |
Jan. 25, 2000 |
| 6017900 |
Topical composition containing hyaluronic acid and nsaids |
Jan. 25, 2000 |
| 6017901 |
Heavy metal salts of succinic acid hemiesters with hyaluronic acid or hyaluronic acid esters, a process for their preparation and relative pharmaceutical compositions |
Jan. 25, 2000 |
| 6015796 |
Method for treating AIDS |
Jan. 18, 2000 |
| 6015799 |
Dextrin sulfates and anti HIV-1 agents and composition thereof |
Jan. 18, 2000 |
| 6013635 |
Treatment of C. difficile toxin B associated conditions |
Jan. 11, 2000 |
| 6013641 |
Use of hyaluronic acid as an immunosuppressant |
Jan. 11, 2000 |
| 6013679 |
Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
Jan. 11, 2000 |
| 6007813 |
Method and composition for treating ulcers and secretion of gastric acid |
Dec. 28, 1999 |
| 6007843 |
Sustained release delivery system |
Dec. 28, 1999 |
| 6008203 |
Methods for treatment of EGF receptor associated cancers |
Dec. 28, 1999 |
| 6004938 |
Inositolglycans having insulin-like action |
Dec. 21, 1999 |
| 6004958 |
Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy |
Dec. 21, 1999 |
| 6001819 |
Bacterial inhibition with an oligosaccharide compound |
Dec. 14, 1999 |
| 6001820 |
Compositions and methods for inhibiting thrombogenesis |
Dec. 14, 1999 |
| 5998363 |
Enteral formulation: low in fat and containing protein hydrolysates |
Dec. 7, 1999 |
| 5998389 |
Endotoxin-specific assay |
Dec. 7, 1999 |
| 5993797 |
Vascular intimal hyperplasia-inhibitory composition |
Nov. 30, 1999 |
| 5994325 |
Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
Nov. 30, 1999 |
| 5989542 |
Capsular polysaccharides from enterococci |
Nov. 23, 1999 |
| 5989592 |
Inhibition of complement pathway by sea cucumber fractions |
Nov. 23, 1999 |
| 5990095 |
Use of hyaluronic acid and forms to prevent arterial restenosis |
Nov. 23, 1999 |
| 5990096 |
Formulations containing hyaluronic acid |
Nov. 23, 1999 |
| 5985259 |
Sustained release ophthalmic antibiotic compositions |
Nov. 16, 1999 |
| 5985284 |
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides |
Nov. 16, 1999 |
| 5985330 |
Inhibition of angiogenesis by sea cucumber fractions |
Nov. 16, 1999 |
| 5985826 |
Methods of using hepatic-directed compounds in pretargeting strategies |
Nov. 16, 1999 |
| 5985850 |
Compositions comprising hyaluronic acid and drugs |
Nov. 16, 1999 |
| 5985851 |
Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof |
Nov. 16, 1999 |
| 5985852 |
Inhibition of selectin binding |
Nov. 16, 1999 |
| 5985916 |
Polymer-platinum compounds |
Nov. 16, 1999 |
| 5980953 |
Anti-inflammatory factor, method of isolation, and use |
Nov. 9, 1999 |
| 5981508 |
Facilitation of repair of neural injury with CM101/GBS toxin |
Nov. 9, 1999 |
|
|
|
